Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Human IL-1 RII, Fc Tag (Cat. No. IL2-H4256) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human IL-1 beta, His Tag (Cat. No. ILB-H51H3) with an affinity constant of 0.571 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
PG-201 | PG-201 | Approved | Viromed | Layla | South Korea | Osteoarthritis | Pmg Pharm Co Ltd | 2012-01-01 | Osteoarthritis | Details |
Edaravone/(+)-2-Decanol | SIM-071201; Y-2 | Approved | Jiangsu Simcere Pharmaceutical Co Ltd | Mainland China | Stroke | Nanjing Simcere Dongyuan Pharmaceutical Co Ltd | 2020-07-29 | Brain Infarction; Intracranial Hemorrhages; Cerebral Hemorrhage; Stroke; Alzheimer Disease; Amyotrophic Lateral Sclerosis | Details | |
Thalidomide | NSC-66847; NSC-527179; K-17; VP-02 | Approved | Celgene Corp | Talizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, Thaled | Japan | Leprosy, Lepromatous | Fujimoto Pharmaceutical | 1982-01-01 | Osteosarcoma; Leprosy, Lepromatous; Drug Resistant Epilepsy; Primary Myelofibrosis; Neuroectodermal Tumors, Primitive; Prostatitis; Colorectal Neoplasms; Lymphoma, Mantle-Cell; Sarcoma, Ewing; Retinoblastoma; Waldenstrom Macroglobulinemia; Cholangitis, Sclerosing; HIV Wasting Syndrome; Arachnoiditis; Adenocarcinoma, Clear Cell; Prostatic Neoplasms; Pancreatitis, Chronic; Lymphoma, Follicular; Sarcoma; Xerostomia; Burning Mouth Syndrome; Neoplasm Metastasis; Mycobacterium avium-intracellulare Infection; Vascular Malformations; Amyotrophic Lateral Sclerosis; Melanoma; Carcinoma, Hepatocellular; Leukemia, Lymphocytic, Chronic, B-Cell; Myelodysplastic-Myeloproliferative Diseases; Stomatitis; Erythema Nodosum; Anemia, Sideroblastic; Uterine Neoplasms; Lymphoma, Non-Hodgkin; Glioma; Angiodysplasia; Pelvic Pain; Appendiceal Neoplasms; Lung Neoplasms; Endometrial Neoplasms; Mycobacterium Infections; Gastric Antral Vascular Ectasia; Carcinoid Tumor; Lupus Erythematosus, Discoid; Stomatitis, Aphthous; Rhabdomyosarcoma; | Details |
Canakinumab | ACZ-885 | Approved | Novartis Pharma Ag | Ilaris | United States | Still's Disease, Adult-Onset | Novartis Pharma Ag | 2009-06-17 | Muscular Dystrophy, Duchenne; Hyperimmunoglobulin D syndrome; Mucocutaneous Lymph Node Syndrome; Cryopyrin-Associated Periodic Syndromes; Arthritis, Gouty; Coronavirus Infections; Cognitive Dysfunction; Sarcoidosis, Pulmonary; Alzheimer Disease; Urticaria; Primary Myelofibrosis; Dry Eye Syndromes; Pulmonary Disease, Chronic Obstructive; Gout; Carcinoma, Non-Small-Cell Lung; Macular Degeneration; Diabetes Mellitus; Behcet Syndrome; Diabetic Retinopathy; Anemia, Sickle Cell; Aortic Aneurysm, Abdominal; Peripheral Arterial Disease; Diabetes Mellitus, Type 2; Familial Mediterranean Fever; Hepatitis, Alcoholic; Prediabetic State; Diabetes Mellitus, Type 1; Atherosclerosis; Mevalonate Kinase Deficiency; Anemia; Schnitzler Syndrome; Pyoderma Gangrenosum; Polyarticular Juvenile Idiopathic Arthritis; Still's Disease, Adult-Onset; Polycythemia Vera; Arthritis, Rheumatoid; Myelodysplastic Syndromes; Hereditary Autoinflammatory Diseases; Vasculitis; Coronavirus Disease 2019 (COVID-19); Chronic Urticaria; Muckle-Wells Syn | Details |
Rilonacept | KPL-914; RGN-303 | Approved | Regeneron Pharmaceuticals Inc | Arcalyst | United States | Pericarditis | Regeneron Pharmaceuticals Inc | 2008-02-27 | Pericarditis; Renal Insufficiency, Chronic; Inflammation; Gout; Scleroderma, Diffuse; Urticaria; Cryopyrin-Associated Periodic Syndromes; Hearing Loss, Sensorineural; Genetic Diseases, Inborn; Familial Mediterranean Fever; Arthritis, Juvenile; Muckle-Wells Syndrome (MWS); Scleroderma, Systemic; Anemia; Schnitzler Syndrome; Diabetes Mellitus, Type 1; Still's Disease, Adult-Onset | Details |
Diacerein | AC-201; AC-203; Art-50; SF-277; CCP-020; KW-4800; AC-201CR | Approved | Verboril, Art, 安必丁, Artrodar, Artrolyt, Cartivix, Fisiodar | Epidermolysis Bullosa, Junctional; Overweight; Epidermolysis Bullosa Dystrophica; Diabetes Mellitus; Osteoarthritis, Hip; Obesity; Osteoarthritis; Arthritis; Diabetes Complications; Diabetes Mellitus, Type 2; Pemphigoid, Bullous; Osteoarthritis, Knee; Epidermolysis Bullosa; Epidermolysis Bullosa Simplex; Coronavirus Disease 2019 (COVID-19); Insulin Resistance; Non-alcoholic Fatty Liver Disease | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
HMPL-004 (Hutchison Medipharma) | HMPL-004 | Details | |||
LY 2189102 | LY-2189102 | Eli Lilly And Company | Details | ||
lutikizumab | ABT-981 | Abbvie Inc | Details | ||
CYT 013 IL1bQb | Kuros Biosciences | Details | |||
Ensereptide | PXL-01 | Phase 3 Clinical | Promore Pharma | Post-surgical adhesions; Cicatrix | Details |
DLX-2323 | DLX-2323 | Phase 1 Clinical | Delenex Therapeutics Ag | Inflammation | Details |
Ajulemic acid | DMH-11C; JBT-101; CPL-7075; DMH-THC-11-OIC; CT-3; HU-239; IP-751 | Phase 3 Clinical | Corbus Pharma | Cystic Fibrosis; Lupus Vulgaris; Dermatomyositis; Lupus Erythematosus, Systemic; Scleroderma, Diffuse | Details |
Goflikicept | RPH-104 | Phase 3 Clinical | Trpharm | Still's Disease, Adult-Onset; Familial Mediterranean Fever; Schnitzler Syndrome; ST Elevation Myocardial Infarction; Coronavirus Disease 2019 (COVID-19); Pericarditis; Gout | Details |
Efprezimod alfa | CD24-Fc; HAS-CD24; CD24-Fc-IgG; MK-7110; MK7110 | Phase 3 Clinical | Oncoimmune Inc | Leukemia; Hematopoietic stem cell transplantation (HSCT); HIV Infections; Solid tumours; Graft vs Host Disease; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Dyslipidemias; Leukemia, Myeloid, Acute; Melanoma | Details |
Kinnazumab | Phase 2 Clinical | Changchun Genescience Pharmaceutical Co Ltd | Solid tumours; Still's Disease, Adult-Onset; Arthritis, Juvenile; Arthritis, Gouty; Gout | Details | |
AK-114 | AK-114; AK114 | Phase 1 Clinical | Zhongshan Akeso Biopharma Co Ltd | Solid tumours; Neoplasms; Inflammation; Neoplasm Metastasis | Details |
Gevokizumab | XMA-005.2; AB-7; XOMA-052; S-78989; VPM-087 | Phase 1 Clinical | Xoma Corp | Colonic Neoplasms; Labyrinth Diseases; Panuveitis; Behcet Syndrome; Osteoarthritis; Uveitis; Colorectal Neoplasms; Cryopyrin-Associated Periodic Syndromes; Arthritis, Rheumatoid; Diabetes Mellitus, Type 1; Hereditary Autoinflammatory Diseases; Diabetes Mellitus, Type 2; Pyoderma Gangrenosum; Esophageal Neoplasms; Carcinoma, Renal Cell; Stomach Neoplasms; Acne Vulgaris | Details |
Recombinant humanized monoclonal antibody antiIL-1β(Cp Guojian) | SSGJ-613 | Phase 2 Clinical | Shanghai Cp Guojian Pharmaceutical Co Ltd | Tumor necrosis factor receptor associated periodic syndrome; Arthritis, Juvenile; Arthritis, Gouty; Gout; Inflammation | Details |
FL-101 | FL-101 | Phase 1 Clinical | Flame Biosciences Inc | Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
CU-06 | CU-06-EYE; CU-06-IBD; CU-061004; Sac-1004; CU-06-ONCO; CU-06-HAE; CU06-1004 | Phase 2 Clinical | Curacle Co Ltd | Myocardial Infarction; Neoplasms; Lung Diseases; Stroke; Diabetic macular oedema; Colitis, Ulcerative; Macular Degeneration; Angioedemas, Hereditary; Crohn Disease; Diabetic Retinopathy | Details |
This web search service is supported by Google Inc.